Patient Details
Full legal name, date of birth, medical record number, and primary contact information used for identification and record matching across clinical systems.
A complete Healthcare Oncology Document clarifies treatment decisions, documents patient consent, and creates an auditable record used for clinical safety, reimbursement, and legal defense; electronic execution is governed by ESIGN (15 U.S.C. ch. 96) and UETA where adopted, while HIPAA governs PHI handling (45 CFR §164.502 et seq.).
Role clarity reduces delays: identify each signer, their authority, and any required witness or notary before initiating the signature workflow.
Full legal name, date of birth, medical record number, and primary contact information used for identification and record matching across clinical systems.
Diagnosis, staging, prior treatments, allergies, current medications, and performance status; provides the clinical basis for proposed oncology interventions.
Clear description of proposed chemotherapy, immunotherapy, radiation, or surgical steps, including regimen, dosing, schedule, and expected benefits and risks.
Plain-language explanation of alternatives, risks, benefits, and uncertainties with explicit patient acknowledgement and signature to document voluntary consent.
Scope and duration for release of medical records, research data sharing permissions, and designated recipients for coordination of care or billing.
Signature blocks for patient/representative, clinician, witness or notary if required, and fields for relationship to patient and signature dates.
Ensure the chosen platform provides retrievable audit trails and the ability to download signed records in standard formats for archival or EHR ingestion.
| Field | Configuration |
|---|---|
| Authentication | Email + SMS code for patient verification |
| Witnessing | Enable witness signature fields where state law requires |
| Record Retention | Enable 6+ years retention for PHI (HIPAA) |
| Audit Trail | Capture IP, timestamps, and signer details |
Obtain informed consent before initiating any oncology treatment.
Respond to patient access requests within 30 days (45 CFR §164.524).
Document and sign any treatment plan changes promptly, typically within 7 days.
Submit claims per payer rules to avoid denials; timelines vary by insurer.
Complete consent before trial procedures or randomization.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day trial, no credit card | Varies by plan | Varies by plan | Varies by plan | Varies by plan |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No cap | 100 envelopes/user/year | Varies | Varies | Varies |
A multidisciplinary team reviews the proposed regimen with the patient and records consent
Research staff explain protocol risks and alternatives before enrollment